The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside experts.
FDA’s AI Rollout Raises Questions Around Readiness, Legality Read More »
Changing how biopharmas package their products, how regulators review new drugs and how mutated genes are fixed could make ultrarare disease treatments possible.
Ultrarare Therapies Could Be Reality with Advances in Tech, Delivery and Regulation Read More »
Soluciones seguras y veloces para guardar contenido multimedia sin complicaciones Cada día aparecen en Instagram millones de clips, fotografías y carruseles que resultan valiosos para investigadores, docentes y profesionales de la divulgación científica. Conserva …
Las 5 mejores herramientas para descargar vídeos y reels al instante Read More »
The high court preserved a key portion of the Affordable Care Act that requires private insurers to cover a range of preventive healthcare services without cost sharing.
Supreme Court upholds ACA preventive services mandate Read More »
The high court preserved a key portion of the Affordable Care Act that requires private insurers to cover a range of preventive healthcare services without cost sharing.
Supreme Court upholds ACA preventive services mandate Read More »
The company began the recall after receiving four field complaints about tip separation before and during use.
Cook Medical recalls catheters over fault linked to 3 serious injuries Read More »
The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to Truist Securities analysts. Meanwhile, the FDA moves forward on having Pfizer/BioNTech and Moderna update labels for their COVID vaccines.
ACIP Skips Votes on COVID and Moderna’s mRESVIA but Scrutinzes mRNA Vaccine Safety Read More »
The high court found that members of a task force that determines what preventive drugs must be covered can be removed at will by HHS Secretary Robert F. Kennedy Jr.
Supreme Court Leaves PrEP Drug Coverage Decisions to RFK’s Task Force Read More »
The FDA found that data from a single Phase II study were “insufficient” to justify an accelerated approval review for sevasemten in Becker muscular dystrophy.
Edgewise Takes a Hit as FDA Blocks Accelerated Path for Becker Muscular Dystrophy Drug Read More »
Carlin will take leadership of the segment as Stryker sees growth in robotic surgeries.
Stryker names Mike Carlin as leader of digital, robotics unit Read More »
